title: Intravenous alanyl-L-glutamine balances glucose-insulin homeostasis and facilitates recovery in patients undergoing colonic resection: a randomised controlled trial.
abstract: BACKGROUND
  Glucose and insulin homeostasis are altered in patients undergoing gastro-intestinal tumour resection and affect the postsurgical outcomes.
  
  
  OBJECTIVE
  To evaluate the impact of dipeptide alanyl-L-glutamine supplementation on glucose-insulin homeostasis, inflammatory mediators and surgical recovery in patients undergoing colonic cancer resection.
  
  
  METHODS
  A randomised controlled trial.
  
  
  METHODS
  Southeast University Affiliated Zhongda Hospital, China, from January 2011 to May 2011.
  
  
  METHODS
  Patients aged 35 to 75 years, ASA physical status I-II, scheduled for elective colon cancer resection.
  
  
  METHODS
  Sixty patients were randomised into one of the three groups and received 22.4 ml kg of physiological saline, a 8.5% 18AA-II solution (a compound amino acid) or glutamine 0.5 g kg, given 24 h before and 1 h after the start of the surgical procedure.
  Insulin resistance index and insulin sensitivity check index. Secondary outcomes included blood glucose, insulin, tumour necrosis factor-alpha (TNF-α) and free fatty acid measured at 24 h before surgery (T1), 30 min before anaesthesia (T2), 2.5 h after the beginning of surgery (T3), and 1 h (T4) and 24 h (T5) after the end of surgery. The time of first passage of wind and the length of hospital stay were recorded.
  
  
  RESULTS
  Intraoperative and postoperative insulin resistance or calculated insulin sensitivity were worse in the physiological saline and 18AA-II treated patients compared with those treated with glutamine (P < 0.05). Blood glucose increased intraoperatively and postoperatively in all three groups compared with baselines (P < 0.05), but glutamine attentuated the peak level of blood glucose (P < 0.05). Glutamine reduced the intraoperative and postoperative concentrations of TNF-α and free fatty acid, (P < 0.05), and shortened the time to the first passage of wind after surgery and the length of hospital stay (P < 0.05).
  
  
  CONCLUSIONS
  Intravenous supplementation with glutamine balances glucose-insulin homeostasis and facilitates recovery in patients undergoing colon cancer resection.
authors.affiliation: From the Department of Anesthesiology, Zhongda Hospital and College of Medicine, Southeast University, Jiangsu, China *Yan Cui and Liang Jing contributed equally to this work.
authors.forename: Yan
authors.initials: Y
authors.lastname: Cui
authors.forename: Liu
authors.initials: L
authors.lastname: Hu
authors.forename: Yue-jiang
authors.initials: YJ
authors.lastname: Liu
authors.forename: Ya-mou
authors.initials: YM
authors.lastname: Wu
authors.forename: Liang
authors.initials: L
authors.lastname: Jing
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000601:surgery*; D004151:Dipeptides / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D005973:Glutamine / Q000008:administration & dosage / Q000494:pharmacology; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011446:Prospective Studies
chemical_list: D001786:Blood Glucose; D004151:Dipeptides; D007328:Insulin; D005973:Glutamine; C054122:alanylglutamine